Published in J Clin Microbiol on October 01, 1991
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev (1992) 4.58
Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect Immun (2003) 1.91
Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol (1997) 1.43
Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis. Clin Diagn Lab Immunol (2000) 1.39
Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value. Clin Vaccine Immunol (2010) 1.19
Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis. Infect Immun (1999) 1.09
Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis. J Clin Microbiol (1992) 1.03
Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis. Arch Immunol Ther Exp (Warsz) (2010) 0.91
Human T cell and antibody-mediated responses to the Mycobacterium tuberculosis recombinant 85A, 85B, and ESAT-6 antigens. Clin Dev Immunol (2010) 0.81
Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun (1991) 4.57
Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen. J Bacteriol (1988) 3.97
The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis (1987) 3.67
Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun (1989) 3.64
The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system. Scand J Immunol (1980) 3.50
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb Pathog (1987) 2.66
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect Immun (1990) 2.06
Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG. Am Rev Respir Dis (1990) 1.86
Serologic diagnosis of bone and joint tuberculosis by an enzyme-linked immunosorbent assay. J Infect Dis (1982) 1.83
Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin. J Clin Microbiol (1988) 1.80
Nucleotide sequence of the 32 kDa-protein gene (antigen 85 A) of Mycobacterium bovis BCG. Nucleic Acids Res (1990) 1.77
An ELISA for the serodiagnosis of tuberculosis using a 30,000-Da native antigen of Mycobacterium tuberculosis. J Infect Dis (1990) 1.65
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 20.55
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med (1996) 5.38
A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol (2003) 4.66
Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun (1989) 3.64
Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med (1995) 3.45
Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.42
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun (1998) 3.14
Lung volumes and forced ventilatory flows. Eur Respir J (1993) 3.00
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med (1996) 2.75
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb Pathog (1987) 2.66
Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun (1992) 2.50
T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun (1994) 2.18
Pulmonary emphysema: quantitative CT during expiration. Radiology (1996) 2.14
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine (1997) 1.83
Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin. J Clin Microbiol (1988) 1.80
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun (2001) 1.60
Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells. Infect Immun (1999) 1.60
Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect Immun (1994) 1.58
Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol (1999) 1.53
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun (2001) 1.50
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol (2000) 1.48
DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun (2000) 1.44
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol (1993) 1.44
Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J Bacteriol (1997) 1.38
CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A. Eur J Immunol (2000) 1.37
Chest wall stiffness in patients with chronic respiratory muscle weakness. Am Rev Respir Dis (1983) 1.34
Inspiratory muscle force in normal subjects and patients with interstitial lung disease. Thorax (1980) 1.30
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. Tuber Lung Dis (1999) 1.27
Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis (2003) 1.26
The effects of age, sex, lung size, and hyperinflation on CT lung densitometry. AJR Am J Roentgenol (1996) 1.25
T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients. Clin Exp Immunol (1991) 1.25
Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines. Infect Immun (2000) 1.24
Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis (1982) 1.24
Non-fibrous inorganic particles in human bronchoalveolar lavage fluids. Scanning Microsc (1989) 1.19
Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia. Am J Hematol (1993) 1.18
[Lung volumes and forced ventilatory flows. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]. Rev Mal Respir (1994) 1.16
Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD. Eur Respir J (1992) 1.13
Dental technician's pneumoconiosis. A report of two cases. Am Rev Respir Dis (1986) 1.11
Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice. Infect Immun (1997) 1.11
Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun (2002) 1.11
Mineralogical analysis of bronchoalveolar lavage in talc pneumoconiosis. Eur J Respir Dis (1987) 1.11
Abdominal muscle use during breathing in patients with chronic airflow obstruction. Am Rev Respir Dis (1992) 1.10
Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G. Infect Immun (1999) 1.10
Testing health care professionals' communication skills: the usefulness of highly emotional standardized role-playing sessions with simulators. Psychooncology (2000) 1.09
Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect Immun (2000) 1.09
Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis (1987) 1.09
Phrenic and diaphragm function after coronary artery bypass grafting. Thorax (1985) 1.09
Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect Immun (2000) 1.08
Fibronectin-binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 response inducers in leprosy contacts. Infect Immun (1995) 1.08
Effects of vagal blockade on lung mechanics in normal man. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.08
Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons. Antiviral Res (1982) 1.07
Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J Clin Microbiol (2001) 1.06
Mineralogical analysis of bronchoalveolar lavage fluid as an aid to diagnosis of "imported" pleural asbestosis. Thorax (1983) 1.05
Occupational lung fibrosis in an aluminium polisher. Eur J Respir Dis (1986) 1.05
Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test. Vaccine (2000) 1.05
Pulmonary mechanics in diffuse fibrosing alveolitis. Bull Physiopathol Respir (Nancy) (1975) 1.05
Two-lung and one-lung ventilation in patients with chronic obstructive pulmonary disease: the effects of position and F(IO)2. Anesth Analg (2000) 1.04
A serine/threonine protein kinase from Mycobacterium tuberculosis. Eur J Biochem (1997) 1.04
Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD. I. CBA/Ca mice are low producers in vivo, but high producers in vitro. Cell Immunol (1983) 1.03
An isoelectric focusing method for the study of the humoral response against the antigen 85 complex of Mycobacterium bovis BCG in the different forms of leprosy. J Immunol Methods (1991) 1.03
Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis. J Clin Microbiol (1992) 1.03
Rib cage and diaphragm-abdomen compliance in humans: effects of age and posture. J Appl Physiol (1985) (1985) 1.03
Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J (1993) 1.03
Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins. Infect Immun (1992) 1.02
The effects of medetomidine, an alpha 2-adrenergic agonist, on ventilatory drive in the dog. Acta Vet Scand Suppl (1989) 1.02
Identification of a second Mycobacterium tuberculosis gene cluster encoding proteins of an ABC phosphate transporter. FEBS Lett (1996) 1.01
What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary? Eur Urol (2000) 1.01
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85. Clin Exp Immunol (2001) 1.01
A multidot immunobinding assay for the serodiagnosis of tuberculosis. Comparison with an enzyme-linked immunosorbent assay. J Immunol Methods (1988) 1.01
Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect Immun (1993) 1.01
Double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with chronic obstructive lung disease. Curr Med Res Opin (1975) 1.00
A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Infect Immun (2003) 1.00
GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol (2007) 1.00
Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group. Scand J Immunol (1997) 0.99
The major secreted antigen complex (Ag 85) from Mycobacterium bovis bacille Calmette-Guérin is associated with protective T cells in leprosy: a follow-up study of 45 household contacts. J Infect Dis (1993) 0.99
A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system. Gene (1996) 0.99
Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA. Cell Mol Biol (Noisy-le-grand) (1997) 0.99
Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med (1983) 0.98
Antimycobacterial antibodies in pleural effusions. Chest (1990) 0.98
Asbestos bodies in bronchoalveolar lavage fluids of brake lining and asbestos cement workers. Br J Ind Med (1990) 0.98
Evolution of intrathoracic airway mechanics during lung growth. J Appl Physiol Respir Environ Exerc Physiol (1978) 0.98
DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand J Immunol (2003) 0.98
Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination. Vaccine (1997) 0.97
Large tidal volume ventilation does not improve oxygenation in morbidly obese patients during anesthesia. Anesth Analg (1995) 0.97